升捷控股(02340.HK)附屬作為第二被吿人接獲傳訊令狀
格隆匯 1 月 18日丨升捷控股(02340.HK)公吿,於2021年1月14日,富勤保險(香港)有限公司作為第一被吿人("第一被吿人")及昇柏營造廠(工程)有限公司(公司的間接全資附屬公司)作為第二被吿人(統稱"該等被吿人")收到幸福醫藥有限公司作為原吿人代表律師在香港高等法院原訟法庭所出具關於針對該等被吿人的高院建築及仲裁訴訟2021年第6號項下傳訊令狀。
如在傳訊令狀所附的申索背書所述,原吿人針對該等被吿人的申索如下:
(1)因該等被吿人違反了日期為2016年2月3日由該等被吿人簽署的保證金,其保證第二被吿人需妥善履約及遵守與原吿人於2016年4月21日簽訂有關元朗元朗工業邨宏樂街50-68號幸福醫藥新廠房發展主要建築工程合約(第二被吿人違反該合約及其在進行工程時造成疏忽);(2)就第二被吿人違反該合約及其在進行工程時造成疏忽而引致進一步及替代性賠償;(3)根據高等法院條例(第4章)第48及49條按法院認為適當的利率和期限裁定的利息;(4)進一步及其他濟助;及(5)訟費。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
![](/hk/assets/image/code.84ab0b.png)
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.